Loading
NYSEHealthcareMedical - Instruments & Supplies
Latest quote
$15.70
+$0.31 · +2.01%
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
Regular session
$15.70
+$0.31 · +2.01%
Regular session · ET · Market data may be delayed.
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
Day range
Current $15.70
52-week range
Current $15.70
Regular session · ET · Market data may be delayed.
GoAI Score
Sell
Valuation
20
Overpriced
Sentiment
54
Mixed
Risk
53
Elevated Risk
Momentum
51
Neutral
Full GoAI research
Thesis, catalysts, evidence, and risk analysis.
Avantor, Inc., a company established in 1904 and based in Radnor, Pennsylvania, is a global provider of vital products and specialized services. Operating across the Americas, Europe, Asia, the Middle East, and Africa, Avantor caters to a wide array of industries, including biopharmaceuticals, healthcare, educational institutions, government bodies, advanced technology firms, and applied materials enterprises. The company's extensive product portfolio features essential materials and consumables, such as high-purity chemicals and reagents, laboratory supplies, custom-formulated silicone materials, tailored excipients, single-use assemblies, process chromatography resins and columns, analytical sample preparation kits, educational and microbiology products, clinical trial kits, peristaltic pumps, and various fluid handling tips. Beyond consumables, Avantor also supplies advanced equipment and instrumentation. This range includes filtration and virus inactivation systems, incubators, analytical devices, evaporators, ultra-low-temperature freezers, biological safety cabinets, and critical environment supplies. Complementing its product offerings, Avantor delivers a suite of crucial services. These encompass on-site laboratory and production support, clinical services, equipment maintenance, comprehensive procurement and sourcing solutions, and specialized biopharmaceutical material scale-up and development expertise.
Day range
Current $15.70
52-week range
Current $15.70
Profitability as a percentage of reported revenue.
Revenue
Operating income
Net income
| Metric (USD) | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 6.55B USD | 6.78B USD | 6.97B USD | 7.51B USD | 7.39B USD |
| Cost of goods sold | 4.41B USD | 4.5B USD | 4.6B USD | 4.91B USD | 4.88B USD |
| Gross profit | 2.14B USD | 2.28B USD | 2.36B USD | 2.6B USD | 2.5B USD |
| Selling, general, and administrative | 1.6B USD | 1.64B USD | 1.51B USD | 1.47B USD | 1.53B USD |
| Operating expenses | 2.39B USD | 1.19B USD | 1.67B USD | 1.47B USD | 1.53B USD |
| Interest expense | 169.8M USD | 218.8M USD | 284.8M USD | 265.8M USD | 217.4M USD |
| Depreciation and amortization | 410.2M USD | 405.5M USD | 402.3M USD | 405.5M USD | 379.2M USD |
| Operating income | −246.2M USD | 1.08B USD | 696.4M USD | 1.13B USD | 972.2M USD |
| Net income | −530.2M USD | 711.5M USD | 321.1M USD | 686.5M USD | 572.6M USD |
Company facts updated Oct 9, 2026.
Recent quarterly results
Recent quarterly results
Third-party consensus; not a GoAI recommendation.
Funds reporting this stock among their holdings, ordered by reported position size.
Vanguard Morningstar Total Stock Market ETFVTI315.91M0.01%2.3T USD0.03%$382.09+0.67%
Vanguard Morningstar Small-Cap ETFVB228.43M0.12%185.3B USD0.03%$289.76+0.74%
U.S. Small Cap Value Portfolio ETF Class SharesDFSV156.12M0.58%26.91B USD0.33%$37.955-0.38%
Vanguard Morningstar Small-Cap Value ETFVBR145.06M0.21%68.2B USD0.05%$234.64+0.31%
Vanguard Extended Market ETFVXF115.4M0.12%95.4B USD0.05%$235.02+0.81%
Dimensional - US Targeted Value ETFDFAT83.9M0.28%30.26B USD0.33%$67.375-0.27%
State Street SPDR S&P MIDCAP 400 ETF TrustMDY77.17M0.30%25.53B USD0.23%$670.77+0.68%
Dimensional - US Small Cap ETFDFAS55.54M0.16%33.8B USD0.31%$78.41+0.40%Vanguard Morningstar Total Stock Market ETFVTIVanguard Morningstar Small-Cap ETFVBU.S. Small Cap Value Portfolio ETF Class SharesDFSVVanguard Morningstar Small-Cap Value ETFVBRVanguard Extended Market ETFVXFDimensional - US Targeted Value ETFDFATState Street SPDR S&P MIDCAP 400 ETF TrustMDYDimensional - US Small Cap ETFDFASAI-generated and delayed market data for informational and educational purposes only. Not investment advice.
